4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with Diabetes Mellitus, Adult-Onset in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, N; Hattori, A; Hosaka, T; Li, Q; Lian, X; Mawatari, K; Nakamura, A; Nakano, M; Nakaya, Y; Shimohata, T; Takahashi, A; Wu, Q; Yoshida, M | 1 |
1 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
NO-1886, a lipoprotein lipase activator, attenuates contraction of rat intestinal ring preparations.
Topics: Animals; Benzamides; Calcium; Diabetes Mellitus, Type 2; Gastrointestinal Motility; Hypolipidemic Agents; In Vitro Techniques; Intestinal Diseases; Intestines; Lipoprotein Lipase Activators; Male; Muscle Contraction; Muscle, Smooth; Myosin-Light-Chain Kinase; Obesity; Organophosphorus Compounds; Peptides; Rats; Rats, Inbred OLETF; Rats, Wistar | 2008 |